Atossa Therapeutics
ATOS
#10717
Rank
ยฃ17.98 M
Marketcap
ยฃ1.80
Share price
2.11%
Change (1 day)
200.10%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -ยฃ27.97 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ25.9 Million a decrease over its 2024 earnings that were of -ยฃ19 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ27.97 Million7.98%
2025 -ยฃ25.9 Million36.33%
2024 -ยฃ19 Million-15.25%
2023 -ยฃ22.42 Million11.62%
2022 -ยฃ20.08 Million30.84%
2021 -ยฃ15.35 Million15.58%
2020 -ยฃ13.28 Million3.41%
2019 -ยฃ12.84 Million51.16%
2018 -ยฃ8.5 Million40.41%
2017 -ยฃ6.05 Million27.54%
2016 -ยฃ4.75 Million-47.49%
2015 -ยฃ9.04 Million-17.25%
2014 -ยฃ10.92 Million35.91%
2013 -ยฃ8.04 Million112.3%
2012 -ยฃ3.79 Million46.53%
2011 -ยฃ2.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.34 B-69,117.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
ยฃ1.02 B-3,755.59%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
ยฃ1.02 B-3,753.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
ยฃ31.04 M-210.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-ยฃ74.07 Million 164.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-ยฃ5.84 Million-79.17%๐Ÿ‡บ๐Ÿ‡ธ USA